TY - JOUR
T1 - Hypothyroidism in Infants after Enteral Administration of Iodinated Contrast Media
T2 - A Rare but Serious Complication
AU - Pijpers, Adinda G. H.
AU - Zwaveling-Soonawala, Nitash
AU - van Schuppen, Joost
AU - Onland, Wes
AU - van Trotsenburg, A. S. Paul
AU - van Heurn, L. W. Ernest
AU - Derikx, Joep P. M.
AU - Mooij, Christiaan F.
N1 - Publisher Copyright:
© 2025 The Author(s). Published by S. Karger AG, Basel.
PY - 2025
Y1 - 2025
N2 - Introduction: Excessive exposure to iodine early in life can cause primary hypothyroidism by failure to escape the Wolff-Chaikoff effect. Although reported for intravenous iodinated contrast medium (ICM) and topical iodine, prospective studies on thyroid function after enterally administered ICM are lacking. This study aimed to determine the occurrence of hypothyroidism after enteral ICM administration in young infants. Methods: Prospective cohort study was conducted between November 1st, 2022, and July 1st, 2024, in infants <6 months of age, who underwent radiological examination (mostly abdominal X-ray, AXR) with enteral ICM administration. Stasis of contrast was evaluated by AXR on day two after ICM administration. Serum thyroid-stimulating hormone (TSH) and free thyroxine (fT4) levels were measured around days 5 and 10 after ICM administration and, if abnormal, repeated on day 15. Results: Thirty-three patients were included. Seventeen patients (51.5%) were born preterm. Stasis of ICM after 2 days was present in 12 of 28 patients (42.9%). In 5 male patients (15.2%), abnormal TSH or fT4 levels were observed during follow-up. One of these 5 patients developed ICM-induced hypothyroidism requiring treatment. In 2 cases, physiological escape of the Wolff-Chaikoff effect was seen. In 2 cases, non-thyroidal illness/hypothyroxinemia of prematurity was observed. Four of the 5 patients with abnormal TSH or fT4 levels were born preterm. Conclusion: In this study, 1 patient developed primary hypothyroidism requiring levothyroxine treatment after enteral ICM administration. We recommend monitoring of thyroid function in infants younger than 6 months after enteral ICM administration, especially in preterm born infants.
AB - Introduction: Excessive exposure to iodine early in life can cause primary hypothyroidism by failure to escape the Wolff-Chaikoff effect. Although reported for intravenous iodinated contrast medium (ICM) and topical iodine, prospective studies on thyroid function after enterally administered ICM are lacking. This study aimed to determine the occurrence of hypothyroidism after enteral ICM administration in young infants. Methods: Prospective cohort study was conducted between November 1st, 2022, and July 1st, 2024, in infants <6 months of age, who underwent radiological examination (mostly abdominal X-ray, AXR) with enteral ICM administration. Stasis of contrast was evaluated by AXR on day two after ICM administration. Serum thyroid-stimulating hormone (TSH) and free thyroxine (fT4) levels were measured around days 5 and 10 after ICM administration and, if abnormal, repeated on day 15. Results: Thirty-three patients were included. Seventeen patients (51.5%) were born preterm. Stasis of ICM after 2 days was present in 12 of 28 patients (42.9%). In 5 male patients (15.2%), abnormal TSH or fT4 levels were observed during follow-up. One of these 5 patients developed ICM-induced hypothyroidism requiring treatment. In 2 cases, physiological escape of the Wolff-Chaikoff effect was seen. In 2 cases, non-thyroidal illness/hypothyroxinemia of prematurity was observed. Four of the 5 patients with abnormal TSH or fT4 levels were born preterm. Conclusion: In this study, 1 patient developed primary hypothyroidism requiring levothyroxine treatment after enteral ICM administration. We recommend monitoring of thyroid function in infants younger than 6 months after enteral ICM administration, especially in preterm born infants.
KW - Free thryroxine
KW - Omnipaque
KW - Preterm
KW - Thyroid dysfunction
KW - Thyroid-stimulating hormone
UR - http://www.scopus.com/inward/record.url?scp=105001726978&partnerID=8YFLogxK
U2 - 10.1159/000544706
DO - 10.1159/000544706
M3 - Article
C2 - 39947153
SN - 1663-2818
JO - Hormone research in paediatrics
JF - Hormone research in paediatrics
ER -